Antonio Pinto

机构：Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ORCID：0000-0002-9425-9026

发表论文 372 篇 · 总被引 9321 次 · h-index 49

代表论文

• Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 34)
• Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial (2025 · Journal of Clinical Oncology · 被引 13)
• Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study (2025 · Blood Advances · 被引 8)
• Instruments to Assess Bidirectional Intimate Partner Violence: A Systematic Review (2025 · Trauma Violence & Abuse · 被引 2)
• The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study (2025 · OncoImmunology · 被引 2)
• Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 1)